NEOSIMPLIX – Trademark Portfolio

Entity Type: 11

NEOSIMPLIX holds 21 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 21 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 19 are pending. Notable registered marks include DR and NEOSIMPLIX. The owner is based in Seoul.

3F Da-101 ho, 39 Gangnam-daero 118-gil, Gangnam-gu

Seoul 06120 , KR

21 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DR
DR
Registered 2025
REJUALL
REJUALL
Pending 2025

Trademark Classifications

NEOSIMPLIX's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (21 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

35
Advertising & Business (6 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does NEOSIMPLIX have?

NEOSIMPLIX has 21 U.S. trademarks filed with the USPTO. Of these, 2 registered, 19 pending.

What trademark classes does NEOSIMPLIX file in?

NEOSIMPLIX files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 35 (Advertising & Business). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are NEOSIMPLIX's most well-known trademarks?

NEOSIMPLIX's registered trademark portfolio includes well-known marks such as DR and NEOSIMPLIX. These are among 2 currently registered trademarks in the portfolio.

What is NEOSIMPLIX's trademark registration success rate?

NEOSIMPLIX has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 19 applications are pending review.